Henrik Lundvall
Henrik has extensive experience in senior roles within international media and tech companies, including TT, Expressen, Microsoft, Axel Springer and Lifesum. At Yazen, he is Head of Content, with responsibility for strategy, marketing and in-app content, working closely with product, medical and tech teams.
Trulicity (dulaglutide) in the treatment of obesity
Trulicity is a medicine that contains the active substance dulaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity (1). The treatment may also contribute to weight loss (2–4).
Saxenda (liraglutide) in the treatment of obesity
Saxenda is a medicine used as support in the treatment of overweight and obesity. It contains the active substance liraglutide, which influences appetite regulation and helps reduce energy intake. When combined with lifestyle changes such as a healthy diet and regular physical activity, the treatment can support clinically significant weight loss (1).
How to reduce the risk of loose skin after weight loss
Weight loss can bring significant positive changes for both health and wellbeing. At the same time, many people experience loose skin after substantial weight loss, especially if the weight has decreased rapidly or if they have lived with overweight or obesity for a long time.
Loose skin is a natural result of changes in the skin’s elasticity as the body adjusts. By understanding how the skin is affected after weight loss and which factors influence its elasticity, you can give the skin better conditions to tighten and feel firmer again.
Ozempic (semaglutide) for the treatment of obesity
Ozempic is a prescription medication used for the treatment of type 2 diabetes as a supplement to diet and exercise. The active substance, semaglutide, contributes to improved blood sugar control and also has an appetite-suppressing effect, which can lead to weight loss.
Wegovy (semaglutide) in the Treatment of Obesity
Wegovy is a prescription medication used for the treatment of obesity and overweight.
It contains the active substance semaglutide and has shown significant effects on weight loss and cardiometabolic risk factors in clinical studies. By affecting the body's appetite regulation, this treatment can lead to an increased feeling of fullness and reduced energy intake.
Are weight loss and fat loss the same thing?
Many people who want to improve their health talk about “losing weight” – but what does that actually mean? Is the goal to weigh less, or to have less body fat? The difference is crucial for both health and results. To choose the right strategy, you need to understand the distinction between weight loss and fat loss. Even though they may sound like the same thing, they have different effects on our bodies and our health.